Background: Liver metastasis is a leading cause of colorectal cancer mortality. Therefore, the underlying mechanism and potential therapeutic target of colorectal cancer liver metastasis urge to be found. Mounting evidence indicates that cancer-derived sialylated IgG promotes tumor formation and progression. However, the role of sialylated IgG in colorectal cancer liver metastasis remains undefined.
Materials And Methods: Analysis of sialylated IgG in paired tumor tissues and adjacent normal tissues from 65 colorectal cancer patients was performed using immunohistochemical staining. Functional assays of sialylated IgG were explored in vitro and in vivo. The downstream target of sialylated IgG was investigated by performing gene-set enrichment analysis, ubiquitination assay, cycloheximide chase assay, acetylation assay and co-immunoprecipitation.
Results: Here, our investigation reveals that sialylated IgG is significantly upregulated in colorectal cancer and that the increase of IgG is positively associated with liver metastasis and poor overall survival in colorectal cancer patients. Sialylated IgG promotes colorectal cancer cell migration, invasion and liver metastasis. Notably, anti-sialylated IgG antibody effectively blocks colorectal cancer liver metastasis in mouse models. Mechanistically, sialylated IgG upregulates c-Myc protein level by decreasing c-Myc ubiquitination. Moreover, we find that p300/CBP can stabilize c-Myc by reducing c-Myc ubiquitination. Overexpression of p300/CBP protects c-Myc protein level from sialylated IgG-knockdown in a lysine acetyltransferase activity-dependent manner. Furthermore, sialylated IgG upregulates p300 protein level through integrin β4-FAK-Src-Erk signaling.
Conclusion: Collectively, these results indicate that a novel sialylated IgG-integrin β4-FAK-Src-Erk-p300-c-Myc signaling pathway promotes colorectal cancer liver metastasis, thus providing potential therapeutic targets for colorectal cancer liver metastasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.neo.2025.101140 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC).
Keio J Med
March 2025
Center for Hereditary Breast and Ovarian Cancer Syndrome, Keio University Hospital, Tokyo, Japan.
Hereditary breast and ovarian cancer syndrome (HBOC) is traditionally associated with mutations in the BRCA1 and BRCA2 genes, predominantly impacting breast, ovarian, pancreatic, and prostate cancers. However, recent research suggests that these mutations may also predispose carriers to a broader spectrum of malignancies, including biliary tract, cervical, colorectal, endometrial, esophageal, and gastric cancers. This review presents findings from extensive datasets, including a significant study from a nationwide Japanese biobank that examined cancer risks in 63,828 patients and 37,086 controls.
View Article and Find Full Text PDFSynthesis, cytotoxicity and HQSAR study of amides-fused isosteviol derivatives as potential anti-colorectal cancer agents.
Fitoterapia
March 2025
Innovative Practice Platform for Research-oriented Teaching of Natural Product Resources Development and Application, School of Food Science and Chemical Engineering, Zhengzhou University of Technology, Zhengzhou, Henan 450044, China.
A series of novel amide-fused isosteviol derivatives were designed and synthesized. Their cytotoxicities in vitro against HCT-116 cells were screened. The preliminary bioassays indicated that most of the title compounds exhibited noteworthy cytotoxicity.
View Article and Find Full Text PDF[A Case of Robot-Assisted Total Pelvic Exenteration for Locally Advanced Rectal Cancer with Vaginal Invasion].
Gan To Kagaku Ryoho
February 2025
Dept. of Gastroenterological Surgery, Sakai City Medical Center.
A 66-year-old woman presented with discharge of necrotic tissue and bleeding from the vagina during uterine cancer screening. She was diagnosed with lower rectal cancer cT4b(vagina)N3M0, cStage Ⅲc. As the tumor protruded into the lumen from the posterior vaginal wall, preservation of the anterior vaginal wall was challenging.
View Article and Find Full Text PDF[Short-Term Outcomes of Robot-Assisted Laparoscopic Surgery for Rectal Cancer in Our Department].
Gan To Kagaku Ryoho
February 2025
Dept. of Surgery, Tokyo Women's Medical University Adachi Medical Center.
We investigated the short-term outcomes of robot-assisted surgery for rectal cancer in our department. Among 98 cases of colorectal cancer who underwent robot-assisted surgery between October 2019 and December 2023, 91 cases of rectal cancer surgery using the da Vinci X surgical system® were included, and clinicopathological and surgical outcomes were examined. The patients included 58 males and 33 females, with a median age of 71 years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!